Temperature sensitivity of human wild-type and mutant p53 proteins expressed in vivo

British Journal of Cancer

Volumn 77, Issue 10, 1998, Pages 1555-1561

  Ponchel, F ^a   Milner, J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Flexible mutant; Function in vivo; Human p53

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ARTICLE; CELL LINE; DNA DAMAGE; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; TRANSACTIVATION;

EID: 0031972272     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.256     Document Type: Article

References (36)

1. Aden DP, Fogel A, Plotkin S, Damjanov I and Knowles BB (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282: 615-616
2. Canman C and Kastan M (1995) Induction of apoptosis by tumor-suppressor genes and oncogenes. Sem Cancer Biol 6: 17-25
3. Cho Y, Gorina S, Jeffrey PD and Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355
4. Fogh J and Trempe G (1975) Human Tumor Cells In Vitro. pp. 115-159. Plenum Press: New York
5. Forrester K, Lupold S, Ott V, Chay C, Band V, Wang X and Harris C (1995) Effects of p53 mutant on wild type p53-mediated transactivation are cell type dependent. Oncogene 10: 2103-2111
6. Frehourg T, Barbier N, Kassel J, Ng YS, Romero P and Friend SH (1992) A functional screen for germ line p53 mutations based on transcriptional activation. Cancer Res 52: 6976-6978
7. Freidman S, Shaulian E, Littlewood T, Resnitzky D and Oren M (1997) Resistance to p53-mediated growth arrest and apoptosis in Hep3B hepatoma cells. Oncogene 15: 63-70
8. Friedlander P, Prives C and Oren M (1996a) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol 16: 4961-4971
9. Friedlander P, Soussi T and Privet C (1996b) Regulation of mutani p53 temperature-sensitive DNA-binding. J Biol Chem 271: 25468-25478
10. Guillot C, Courtois S, Voeltzel T, Garcia E, Ozturk M and Puisieux A (1996) Alteration of p53 damage response by tamoxifen treatment. Clin Cancer Res 2: 1439-1444
11. Hainaut P and Milner J (1992) Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. EMBO J 11: 3513-3520
12. Hainaut P and Milner J (1993a) Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 59: 4469-1473
13. Hainaut P and Milner J (1993b) A structural role for metal ions in the 'wild-type' conformation of the tumor suppressor protein p53. Cancer Res 53: 1739-1742
14. Hainaut P (1995a) The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr Opin Oncol 7: 76-82
15. Hainaut P, Butcher S and Milner J (1995b) Temperature sensitivity for conformation is an intrinsic property of wild type p53. Br J Cancer 71: 227-231
16. Hall AJ and Milner J (1995) Structural and kinetic-analysis of p53-DNA complexes and comparison of human and murine p53. Oncogene 10: 561-567
17. Hansen S, Hupp T and Lane D (1996) Allosteric regulation of the thermostability and DNA-binding activity of human p53 by specific interacting proteins. J Biol Chem 271: 3917-3924
18. Haupt Y and Oren M (1996) Cell-type-specific inhibition of P53-mediated apoptosis by mdm2. EMBO J 15: 1596-1606
19. Haupt Y, Rowan S, Shaulian E, Vousden K and Oren M (1995) Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev 9: 2170-2183
20. Haupt Y, Maya R, Kazaz A and Oren M (1997) Mdm-2 promotes the rapid degradation of p53. Nature 387: 296-298
21. Ichikawa D, Yamaguchi T, Shirasu M, Kitamura K, Inazawa J, Abe T and Takahasi T (1996). p53 gene mutation is not directly related to tumoricidal effects of preoperative radiochemohyperthermia therapy for rectal cancers. J Surg Oncol 63: 89-90
22. Jiang M, Lin J and Yen J (1996) Differential regulation of p53. c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 13: 609-616
23. Ko LJ and Prives C (1996) P53 - puzzle and paradigm. Genes Dev 10: 1054-1072.
24. Kubbutat M, Jones S and Vousden K (1997) Regulation of p53 stability by mdm-2. Nature 387: 299-302
25. Maniatis T, Goodbourn S and Fischer JA (1987) Regulation of inducible and tissue-specific gene expression. Science 236: 1237-1244
26. Medcalf EA, Takahashi T, Chiba I, Minna J and Milner J (1992) Temperaturesensitive mutants of p53 associated with human carcinoma of the lung Oncogene 7: 71-76
27. Michalovitz D, Halevy O and Oren M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671-680
28. Milner J (1995) DNA damage. p53 and anticancer therapies. Nature Med 1: 879-880
29. Milner J and Medcalf EA (1990). Temperature-dependent switching between 'wild-type' and 'mutant' forms of p53-Vall 35. J Mol Biol 216: 481-484
30. Muller M, Strand S, Hug H, Heinemann E, Walczak H, Hoffmann W, Stremmel W, Kramer P and Galle P (1997) Drug induced apoptosis in hepatoma cells is mediated by the CD95 (APO-I/Fas) receptor/ligand system and involves activation of wild type p53. J Clin Invest 99: 403-413
31. Ogretmen B and Safa A (1997) Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterisation in multidrug resistant MCF-7/Adr human breast cancer cells. Onocgene 14: 499-506
32. Ponchel F, Puisieux A, Tabone E, Michot JP, Froschl G, Morel AP, Frebourg T, Fontaniere B, Oberhammer F and Ozturk M (1994) Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res 54: 2064-2068
33. Rolley N, Butcher S and Milner J (1995) Specific DNA binding by different classes of human p53 mutant. Oncogene 11: 763-770
34. Soule H (1973) J Natl Cancer Inst 51: 1409-1416
35. Verhgaegh W, Richard M and Hainaut P (1997) Regulation of p53 by metal ion and antioxydant:dithiocarbanate down regulate p53-DNA binding activity by increasing the intracellular level of copper. Mol Cell Biol 17: 5699-5706
36. Yamato K, Hiramo Y and Tsuchida N (1995) A human temperature-sensitive p53 mutant P53 (Val-1.38) - modulation of the cell-cycle, viability and expression of p53-responsive genes. Oncogene 11: 1-6